[
  {
    "ts": null,
    "headline": "Is Merck & Co. (MRK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?",
    "summary": "We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best pharma stocks to invest in now amid the domestic manufacturing boom. Trump Incentivizes Pharmaceuticals to Build Domestic […]",
    "url": "https://finnhub.io/api/news?id=23dad6a94f18af3633ab0fc556e97c1189adc018809b19edf3ad692a3de101a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747170389,
      "headline": "Is Merck & Co. (MRK) the Best Pharma Stock to Invest in Amid the Domestic Manufacturing Boom?",
      "id": 134460893,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other best pharma stocks to invest in now amid the domestic manufacturing boom. Trump Incentivizes Pharmaceuticals to Build Domestic […]",
      "url": "https://finnhub.io/api/news?id=23dad6a94f18af3633ab0fc556e97c1189adc018809b19edf3ad692a3de101a8"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma Counted on This Loophole. It May Be Closing.",
    "summary": "Big Pharma Counted on This Loophole. It May Be Closing.",
    "url": "https://finnhub.io/api/news?id=00363408f3372c83ebe1905f43bf95890be3b06d1c40df5f3fa24371493194b8",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747155180,
      "headline": "Big Pharma Counted on This Loophole. It May Be Closing.",
      "id": 134437979,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Big Pharma Counted on This Loophole. It May Be Closing.",
      "url": "https://finnhub.io/api/news?id=00363408f3372c83ebe1905f43bf95890be3b06d1c40df5f3fa24371493194b8"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma Counted On a Price Negotiation Loophole. It May Be Closing.",
    "summary": "Big Pharma Counted On a Price Negotiation Loophole. It May Be Closing.",
    "url": "https://finnhub.io/api/news?id=7d35b85b2f05094f233b38a4171fa62cde8e4585f5b0e055c8c75b9373ac287c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747144500,
      "headline": "Big Pharma Counted On a Price Negotiation Loophole. It May Be Closing.",
      "id": 134403148,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Big Pharma Counted On a Price Negotiation Loophole. It May Be Closing.",
      "url": "https://finnhub.io/api/news?id=7d35b85b2f05094f233b38a4171fa62cde8e4585f5b0e055c8c75b9373ac287c"
    }
  },
  {
    "ts": null,
    "headline": "Research on Novel Treatment Approaches and Scientific Advances From Merck’s Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025",
    "summary": "RAHWAY, N.J., May 13, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research across more than 25 types of cancer and multiple treatment settings from the company’s broad and differentiated portfolio and pipeline will be showcased at the American Society of Clinical Oncology (ASCO) Annual Meeting (May 30–June 3). Data highlight Merck’s commitment to rapidly advance research across multiple tumor types and continue to build on its portfolio of e",
    "url": "https://finnhub.io/api/news?id=79670c28907427c9a212e426525a4ff0302dafecf7bf417ba7351ed5b050958d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747133100,
      "headline": "Research on Novel Treatment Approaches and Scientific Advances From Merck’s Broad and Differentiated Oncology Portfolio and Pipeline to be Presented at ASCO 2025",
      "id": 134408765,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., May 13, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new research across more than 25 types of cancer and multiple treatment settings from the company’s broad and differentiated portfolio and pipeline will be showcased at the American Society of Clinical Oncology (ASCO) Annual Meeting (May 30–June 3). Data highlight Merck’s commitment to rapidly advance research across multiple tumor types and continue to build on its portfolio of e",
      "url": "https://finnhub.io/api/news?id=79670c28907427c9a212e426525a4ff0302dafecf7bf417ba7351ed5b050958d"
    }
  },
  {
    "ts": null,
    "headline": "Dow's 150-point fall led by losses for UnitedHealth, Merck stocks",
    "summary": "Dow's 150-point fall led by losses for UnitedHealth, Merck stocks",
    "url": "https://finnhub.io/api/news?id=62c04e7ffe917c2a19078127aff197dbe8830b6dd6f1239e053ec28ff2ea138d",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747129500,
      "headline": "Dow's 150-point fall led by losses for UnitedHealth, Merck stocks",
      "id": 134402141,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Dow's 150-point fall led by losses for UnitedHealth, Merck stocks",
      "url": "https://finnhub.io/api/news?id=62c04e7ffe917c2a19078127aff197dbe8830b6dd6f1239e053ec28ff2ea138d"
    }
  },
  {
    "ts": null,
    "headline": "One estimate of the profit hit from Trump's executive order on drug pricing",
    "summary": "One estimate of the profit hit from Trump's executive order on drug pricing",
    "url": "https://finnhub.io/api/news?id=31002be2202364c7d16f7dfe775830252e465b3bbd369109954fadbb022e5276",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747117031,
      "headline": "One estimate of the profit hit from Trump's executive order on drug pricing",
      "id": 134403150,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "One estimate of the profit hit from Trump's executive order on drug pricing",
      "url": "https://finnhub.io/api/news?id=31002be2202364c7d16f7dfe775830252e465b3bbd369109954fadbb022e5276"
    }
  }
]